Healthpeak Properties (NYSE:DOC) Price Target Raised to $24.00 at Robert W. Baird

Healthpeak Properties (NYSE:DOC) had its price target lifted by research analysts at Robert W. Baird from $21.00 to $24.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage presently has an “outperform” rating on the real estate investment trust’s stock. Robert W. Baird’s target price would indicate a potential upside of 16.34% from the stock’s previous close.

Other equities analysts have also recently issued research reports about the stock. Raymond James Financial assumed coverage on shares of Healthpeak Properties in a research report on Wednesday, June 17th. They set a “market perform” rating on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Healthpeak Properties in a research note on Wednesday, August 5th. Wall Street Zen raised Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Sunday, May 10th. Royal Bank Of Canada lifted their target price on Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday. Finally, UBS Group boosted their price target on Healthpeak Properties from $19.00 to $21.50 and gave the company a “neutral” rating in a report on Wednesday, July 8th. Four research analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $21.44.

Healthpeak Properties Stock Up 0.6%

DOC stock opened at $20.63 on Thursday. The company has a current ratio of 3.02, a quick ratio of 3.02 and a debt-to-equity ratio of 1.06. The firm has a 50 day simple moving average of $21.29 and a 200-day simple moving average of $18.87. The company has a market capitalization of $14.22 billion, a P/E ratio of 58.94, a PEG ratio of 3.15 and a beta of 1.01. Healthpeak Properties has a twelve month low of $15.70 and a twelve month high of $22.95.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. The firm had revenue of $771.58 million for the quarter, compared to the consensus estimate of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The firm’s revenue was up 11.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. On average, equities research analysts predict that Healthpeak Properties will post 1.77 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Healthpeak Properties

Large investors have recently bought and sold shares of the business. Integrated Wealth Concepts LLC raised its position in shares of Healthpeak Properties by 7.3% during the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock worth $366,000 after purchasing an additional 1,231 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Healthpeak Properties by 110.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock worth $2,463,000 after acquiring an additional 63,930 shares during the period. Woodline Partners LP lifted its position in Healthpeak Properties by 41.3% in the 1st quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock valued at $1,195,000 after purchasing an additional 17,279 shares during the last quarter. Brown Advisory Inc. grew its position in Healthpeak Properties by 3.1% in the 2nd quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock worth $819,000 after purchasing an additional 1,415 shares during the last quarter. Finally, Qube Research & Technologies Ltd bought a new stake in shares of Healthpeak Properties during the second quarter valued at approximately $3,117,000. Institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.